Company / Operating Income per Share
Nuo Therapeutics, Inc. Operating Income per Share History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.56
FY2017
5-year range
-$1.56 / -$0.04
FY2013-FY2017
Trend
-3503.3%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed -3503% YoY in FY2017, a notable deviation from the 6-year average annual change of -609%.
Based on SEC 10-K filings.
-1.56 in FY2017.
Declined from $-0.33 to $-1.56 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, operating income per share decreased 3503.3% year-over-year.
- Peak operating income per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | -$1.56 | -3503.3% |
| FY2016 | -$0.04 | +86.8% |
| FY2015 | -$0.33 | -50.6% |
| FY2014 | -$0.22 | -13.2% |
| FY2013 | -$0.19 | +16.9% |
| FY2012 | -$0.23 | -191.4% |
| FY2011 | -$0.08 | - |
As of FY2017 · SEC 10-K · Updated Jun 29, 2026